2C and D includes OS and RFS curves based on the expression of CD133; patients with CD133-positive tumors had a higher risk of mortality that was trending towards significance (P=0.052) and a significantly higher risk of disease recurrence (P=0.023) than CD133-negative patients.
← all excerpts
CD133 expression and α-fetoprotein levels define novel prognostic subtypes of HBV-associated hepatocellular carcinoma: A long-term follow-up analysis.
1
0.0520
0.0520